Gail H Marracci from 34377 Sunset Dr, Scappoose, OR 97056, age 66, Phone: 503 543-3555

Cyclic Undecapeptides And Derivatives As Multiple Sclerosis Therapies
view source
US Patent:

20100196317, Aug 5, 2010
Filed:

Sep 26, 2008
Appl. No.:

12/679778
Inventors:

Michael Forte - Portland OR, US
Dennis Bourdette - Portland OR, US
Gail Marracci - Scappoose OR, US
International Classification:

A61K 38/13
A61K 38/21
A61K 39/395
C07K 7/64
A61P 25/28
US Classification:

424 856, 514 11, 4241411, 4241331, 530317
Abstract:

A method for treating a subject with multiple sclerosis is disclosed herein. In one embodiment, a method is provided for treating a subject with multiple sclerosis that includes administering to the subject a therapeutically effective amount of a cyclosporin compound.

Sobetirome In The Treatment Of Myelination Diseases
view source
US Patent:

20200405669, Dec 31, 2020
Filed:

Jul 7, 2020
Appl. No.:

16/922852
Inventors:

- Portland OR, US
- Washington DC, US
Andrew Placzek - Portland OR, US
Marco Righi - Rosignano, IT
Dennis Bourdette - Portland OR, US
Gail Marracci - Portland OR, US
Priya Chaudhary - Portland OR, US
Assignee:

Oregon Health & Science University - Portland OR
The United States Government as represented by the Department of Veterans Affairs - Washington DC
International Classification:

A61K 31/192
A61K 9/00
Abstract:

Methods of treating a subject having or at risk of developing a neurodegenerative disease or condition associated with demyelination, insufficient myelination, or underdevelopment of myelin sheath are described. The methods include administration of a therapeutically effective amount of sobetirome, or a pharmaceutically acceptable salt thereof.

Sobetirome In The Treatment Of Myelination Diseases
view source
US Patent:

20190175531, Jun 13, 2019
Filed:

Feb 13, 2019
Appl. No.:

16/275117
Inventors:

- Portland OR, US
- Washington DC, US
Andrew Placzek - Portland OR, US
Marco Righi - Rosignano, IT
Dennis Bourdette - Portland OR, US
Gail Marracci - Portland OR, US
Priya Chaudhary - Portland OR, US
Assignee:

Oregon Health & Science University - Portland OR
The United States Government as respresented by the Department of Veterans Affairs - Washington DC
International Classification:

A61K 31/192
A61K 9/00
Abstract:

Methods of treating a subject having or at risk of developing a neurodegenerative disease or condition associated with demyelination, insufficient myelination, or underdevelopment of myelin sheath are described. The methods include administration of a therapeutically effective amount of sobetirome, or a pharmaceutically acceptable salt thereof.

Sobetirome In The Treatment Of Myelination Diseases
view source
US Patent:

20160081955, Mar 24, 2016
Filed:

Feb 5, 2014
Appl. No.:

14/888577
Inventors:

- Portland OR, US
- Washington DC, US
Andrew Placzek - Portland OR, US
Marco Righi - Rosignano, IT
Dennis Bourdette - Portland OR, US
Gail Marracci - Portland OR, US
Priya Chaudhary - Portland OR, US
Assignee:

Oregon Health & Science University - Portland OR
The United States Government as respresented by the Department of Veterans Affairs - Washington DC
International Classification:

A61K 31/192
A61K 9/00
Abstract:

Methods of treating a subject having or at risk of developing a neurodegenerative disease or condition associated with demyelination, insufficient myelination, or underdevelopment of myelin sheath are described. The methods include administration of a therapeutically effective amount of sobetirome, or a pharmaceutically acceptable salt thereof.